Genetic

Latest Innovations

Therapeutic Agents for Treatment of Myotonic Dystrophy

 

Dr. Zimmerman's lab has developed a series of bioactive compounds for the treatment of myotonic dystrophy. The compounds disrupt the MBNL-(CUG) foci in vivo and...

Bioresorbable Silicon Electronics for Neural Sensing

Dr. John Rogers from the University of Illinois at Urbana-Champaign has developed bioresorbable silicon electronics that can be used for real-time sensing of neural...

Quantum Dots with Thin Coatings that Allow for Efficient Bioconjugation

Dr. Andrew Smith from the University of Illinois has developed new quantum dots with a multidentate polymer coating that minimizes size while maintaining stability and...

Algorithm Modified Deoxynybomycin for the Treatment of Gram-Negative Bacteria

Dr. Hergenrother from the University of IL has developed a novel antibiotic that is effective against certain antibiotic-resistant gram-negative bacteria. His powerful...

Ligand for Potential Treatment of Myotonic Dystrophy Type 1 (DM1)

Dr. Zimmerman from the University of Illinois at Urbana-Champaign has developed an oligomeric ligand that can have potential...

CRISPR-SKIP System to Modulate Expression of Exons & Improve Cellular Delivery of DNA Editing Systems

Dr. Perez-Pinera has developed a new way to edit genes using CRISPR technology that promises to be safer and more efficient that existing technologies. His method uses...